spacer

International Clinical Trials
International Clinical Trials
ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
 
European Pharmaceutical Contractor
European Pharmaceutical Contractor
The EPC edition is designed to fill a unique position in pharmaceutical contractor publishing.
 
European Biopharmaceutical Review
European Biopharmaceutical Review
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
 
Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer
PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
 
Innovations in Pharmaceutical Technology
Innovations in Pharmaceutical Technology
IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.
 
Therapeutic Focus: Dementia
New Frontiers in Alzheimer’s Disease Research

The Practical Alternative

The failures of Alzheimer’s disease research have opened up new approaches to achieve an earlier diagnosis and a more effective treatment approach, argues Timothy Earle at TauRx Theraputics.
 
Good Clinical Practice
Expert Guidance on Inspection Processes

Dispelling the Fears of Inspection

NIHR’s Ross Downes guides you through the daunting process of GCP and MHRA inspections, from documentation and recruitment strategy to the importance of obtaining consent.
 
Vaccine Controversy
Diagnostic Reagents in Dengue Vaccine Development

Going Viral

The Native Antigen Company’s Dr Andy Lane discusses life-threatening flaviviruses such as the Dengue virus, and considers the part vaccines have to play in the combat and eventual eradication of these viruses.
 
Feature topics
Track and Trace Technologies

A Vision of Full Integration

Federico Piutti at Bormioli Pharma supports the trend towards more digital technologies and serialisation in the supply chain, as he believes these technologies will allow for a safer supply of drugs to patients.

 

 

Website design and development by Rubler Studio
spacer

Member login

E-mail address:

Password:
Remember me

.
News and Press Releases

Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey

PHILADELPHIA, PA – January 16, 2020: Signant Health, released the findings from its latest “State of eConsent” report today, highlighting the sentiments, successes, and challenges of eConsent practitioners around the world. Join Signant Health’s webinar on February 12, 2020 at 11am ET or 3pm ET to learn more about the findings.
More info >>

.
White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>



Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement